Our main sectors :
We design contamination-free laboratories, cleanrooms and sterile environments, tailored to the customer's requirements for particle classification and control of production environments. Our comprehensive services include consulting, design, engineering, project management, commissioning and revamping.
Our main sectors :
is the amount the global pharmaceutical market is expected to reach by 2025
is the projected growth rate for the biotechnology market.
organic products is projected as manufacturers implement organic standards
At Egis, we understand that our clients balance costly R&D with large-scale production. We adapt to faster development times, personalized medicine, developments in Innovative Therapeutic Medicines (ITMs), with the combined constraints of chemical and biological manufacturing processes, AI-driven drug discovery, and global competition, while ensuring quality control and regulatory compliance through innovative solutions in contamination control, controlled environments, and energy-efficient designs. We deliver sustainable value with tailored, compliant solutions leveraging global expertise and local knowledge.
We prioritize close collaboration with our clients to fully understand their expectations and offer tailored solutions. Our approach integrates the latest technological innovations and sustainable practices to ensure quality, safety, and efficiency. We work hand-in-hand with technical teams and external partners to deliver successful projects that meet rigorous industry standards.
Egis provides interdisciplinary services that encompass consultancy, design, project and construction management, commissioning as well as the revamping and energy optimization of existing sites. Our team is dedicated to supporting clients navigate the complexities of regulatory compliance, ensuring their products meet the highest standards of safety and efficacy. Whether working on new projects or revamping existing and operating facilities through transfer, reallocation, or extension, we provide tailored solutions to meet diverse needs while systematically maintaining the strong constraint of energy sobriety.
Our collaborations not only involve large pharmaceutical companies, but also mid-sized companies, biotech firms, contract development and manufacturing organisations (CDMOs) and medical device manufacturers. By working with a wide range of clients, we use our expertise to support innovation and growth across the Life Science sector, ensuring that all projects benefit from our commitment to excellence and quality
Key areas of expertise: